Juan Quiles

Juan Quiles

Auto-generated profile, based on publicly available information

Juan Quiles

Hospital Universitario de San Juan, Alicante, Spain

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in JACC
Verified
Journal Article
Closed access
MGMiguel Ngel García-Fernández
Miguel Ngel García-Fernández
EDEsther Pérez David
Esther Pérez David
JQJuan Quiles
Juan Quiles
JPJuan Peralta
Juan Peralta
IGIsmael García-Rojas
Ismael García-Rojas
JSJacobo Silva
Jacobo Silva

19 December 2005 in Heart
Verified
Journal Article
Open access
PDF file
DRD Roy
D Roy
JQJ Quiles
J Quiles
DGD C Gaze
D C Gaze
PCP Collinson
P Collinson
JKJ C Kaski
J C Kaski
GBGary Francis Baxter
Gary Francis Baxter
All reagents were obtained from Sigma-Aldrich (Poole, Dorset, UK) and normal human serum from the North London Transfusion Service (London, UK). Serum pH was 7.35–7.45 at 37°C and was unaltered by any of the reactants during the 15 minute experimental time course. Five millilitre serum aliquots (eight replicate experiments per group) were randomly selected for the following incubations for 15 minutes at 37°C. Group 1, peroxide treated (H2O2): serum was incubated with H2O2 100 μM. Group 2, superoxide treated (•O2−): serum was incubated with a xanthine-xanthine oxidase •O2− generating system consisting of 100 μM xanthine plus 0.05 U/ml xanthine oxidase (xanthine → urate− + •O2−). Group 3, hydroxyl treated (•OH): •OH was generated by the Fenton reaction and Cu2+ 0.1 mmol/l catalysed the generation of •OH from H2O2 100 μM (H2O2 + Cu+ → •OH + OH− + Cu2+. Group 4, Cu2+ control: aliquots of serum were incubated with 0.1 mM CuSO4 as a technical control for group 3. Group 5, •OH + MPG treated: aliquots of serum were incubated with the •OH generating mixture (as in group 3) with the addition of MPG 1 mM. Group 6, control: serum was incubated for 15 minutes without the addition of any reactants.

14 July 2004 in Heart
Verified
Journal Article
Open access
PDF file
Pablo AvanzasPablo Avanzas
Pablo Avanzas
RAR Arroyo-Espliguero
R Arroyo-Espliguero
JCJ Cosín-Sales
J Cosín-Sales
GAG Aldama
G Aldama
CPC Pizzi
C Pizzi
JKJuan Carlos Kaski
Juan Carlos Kaski
Objective: To assess the relation between markers of inflammation and the presence of multiple vulnerable plaques in patients with non-ST segment elevation acute coronary syndromes. Design: Prospective cohort study of 55 patients with non-ST segment elevation acute coronary syndromes and angiographically documented coronary disease. Blood samples were obtained at study entry for the assessment of high sensitivity C reactive protein (CRP), neopterin, and neutrophil count. Coronary stenoses were assessed by quantitative computerised angiography and classified as “complex” (irregular borders, ulceration, or filling defects) or “smooth” (absence of complex features). Extent of disease was also assessed by a validated angiographic score. Results: Neutrophil count (r = 0.36, p = 0.007), CRP concentration (r = 0.33, p = 0.02), and neopterin concentration (r = 0.45, p < 0.001) correlated with the number of complex stenoses. Patients with multiple (three or more) complex stenoses, but not patients with multiple smooth lesions, had a higher neutrophil count (5.9 (1.4) × 109/l v 4.8 (1.4) × 109/l, p = 0.02), CRP concentration (log transformed) (1.08 (0.63) v 0.6 (0.6), p = 0.03), and neopterin concentration (log transformed) (0.94 (0.18) v 0.79 (0.15), p = 0.002). Multiple regression analysis showed that neopterin concentration (B = 4.8, 95% confidence interval (CI) 1.9 to 7.7, p = 0.002) and extent of coronary artery disease (B = 0.6, 95% CI 0.03 to 1.2, p = 0.04) were independently associated with the number of complex stenoses. Conclusions: Acute inflammatory markers such as high neutrophil count, CRP concentration, and neopterin concentration correlate with the presence of multiple angiographically complex coronary stenoses. Neopterin concentration was a stronger predictor of multiple complex plaques than were neutrophil count and CRP concentration. These findings suggest that a relation exists between inflammation and pancoronary plaque vulnerability.

31 January 2005 in European Heart Journal
Verified
Journal Article
Open access
PDF file
Pablo AvanzasPablo Avanzas
Pablo Avanzas
RARamon Arroyo-Espliguero
Ramon Arroyo-Espliguero
JQJuan Quiles
Juan Quiles
DRDebashis Roy
Debashis Roy
JKJuan Carlos Kaski
Juan Carlos Kaski
Aims Serum levels of neopterin, an immune modulator secreted by activated macrophages, are elevated in patients with acute coronary syndromes compared with stable angina patients and control subjects. In unstable angina, serum neopterin levels correlate with the presence of vulnerable coronary stenosis, multiple complex coronary lesions, and patient outcome. The present study assessed the prognostic significance of raised serum neopterin concentrations in patients with stable angina pectoris. Methods and results We carried out a 1-year follow-up prospective study in 297 patients with chronic stable chest pain undergoing diagnostic coronary angiography. The primary study endpoint was the composite of non-fatal myocardial infarction, unstable angina, and cardiac death. Fifty-one patients (17.2%) had adverse coronary events during follow-up. Mean serum neopterin levels were significantly higher in patients with events compared with those without (P=0.02). On multiple regression analysis, neopterin levels (P=0.021), severity of coronary artery disease (P=0.009), and a history of previous myocardial infarction (P=0.001) were independent predictors of adverse events. Conclusions Serum neopterin is an independent predictor of major adverse coronary events in patients with chronic stable angina pectoris. This marker of macrophage activation may be useful for risk stratification in patients with chronic stable angina.

1 September 2004 in Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
DRDebashis Roy
Debashis Roy
JQJuan Quiles
Juan Quiles
RSRajan Sharma
Rajan Sharma
MSManas Sinha
Manas Sinha
Pablo AvanzasPablo Avanzas
Pablo Avanzas
JKJuan Carlos Kaski
Juan Carlos Kaski
Background: Ischemia-modified albumin (IMA) is a new marker of myocardial ischemia, there is concern that IMA concentrations may be affected by ischemia occurring in tissues other than the myocardium. Methods: We assessed 23 consecutive patients (15 males; mean age, 67 years) with typical leg claudication and documented peripheral vascular disease (PVD). All patients underwent both treadmill-exercise stress testing to induce leg ischemia and dobutamine stress echocardiography 1 week apart for the assessment of myocardial ischemia. Blood samples for IMA measurements were obtained at baseline, immediately after peak exercise/stress, and 1 h after exercise/stress. Statistical analysis was performed with the ANOVA repeated-measures test. Results: Compared with baseline, mean (SD) IMA was significantly lower after the induction of skeletal muscle ischemia and returned to baseline values at 1 h: baseline, 74.6 (15.6) kilounits/L; peak stress, 69.5 (14.0) kilounits/L (P <0.0001 vs baseline); 1 h after stress, 75.9 (15.7) kilounits/L (P <0.0001 vs peak stress; P = 0.3 vs baseline). Baseline, peak stress, and 1-h poststress IMA concentrations were inversely correlated with the ankle-brachial index after exercise (r = −0.4; P <0.05). None of the patients showed regional wall motion abnormalities during dobutamine stress echocardiography, and IMA concentrations remained unchanged from baseline. There were no differences in baseline [74.6 (15.6) vs 72.7 (11.5) kilounits/L; P = 0.6], peak stress, or poststress IMA concentrations when exercise testing and dobutamine stress echocardiography values were compared. Conclusions: The relationship between disease severity (of a noncardiac origin) and baseline IMA values is an important and novel finding. IMA is significantly lower immediately after exercise-induced leg ischemia in patients with PVD and is related to disease severity. IMA concentrations can therefore be affected by the development of skeletal muscle ischemia, and this may have implications regarding the ability of IMA to detect myocardial ischemia in PVD patients.

1 November 2004 in International Journal of Cardiology
Verified
Journal Article
Closed access
DRDebashis Roy
Debashis Roy
JQJuan Quiles
Juan Quiles
GAGuillermo Aldama
Guillermo Aldama
MSManas Sinha
Manas Sinha
Pablo AvanzasPablo Avanzas
Pablo Avanzas
JKJuan Carlos Kaski
Juan Carlos Kaski